Terms: = Prostate cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997
45432 results:
1. Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT.
Rosar F; Burgard C; David S; Marlowe RJ; Bartholomä M; Maus S; Petto S; Khreish F; Schaefer-Schuler A; Ezziddin S
Sci Rep; 2024 May; 14(1):11271. PubMed ID: 38760451
[TBL] [Abstract] [Full Text] [Related]
2. Incretin-based drugs decrease the incidence of prostate cancer in type 2 diabetics: A pooling-up analysis.
Lin Y; Xu G; Li L; Xiang J; Zhai L
Medicine (Baltimore); 2024 May; 103(20):e38018. PubMed ID: 38758855
[TBL] [Abstract] [Full Text] [Related]
3. Do alpha blockers reduce the risk of urinary retention post-transperineal prostate biopsy? A systematic narrative review.
Alhamdani Z; Poppenbeek S; Bolton D; Wong LM; Sethi K
World J Urol; 2024 May; 42(1):332. PubMed ID: 38758413
[TBL] [Abstract] [Full Text] [Related]
4. Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced prostate cancer From Latin America: Challenges and Future Approaches.
Manneh R; Verson CA; Martin A; Delgado A; Isaacsson Velho PH; Manduley A; Tejado L; Rodríguez Y; Vargas C; Barata PC
JCO Precis Oncol; 2024 May; 8():e2300628. PubMed ID: 38748947
[TBL] [Abstract] [Full Text] [Related]
5. The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Baudewyns A; Guenzel K; Halinski A; Dariane C; Delavar G; Anract J; Barry Delongchamps N; Jabbour T; Bourgeno HA; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Oderda M; Gontero P; Bernal-Gomez A; Mastrorosa A; Roche JB; Zahr RA; Ploussard G; Fiard G; Rysankova K; Bui AP; Taha F; Windisch O; Benamran D; Vlahopoulos L; Assenmacher G; Roumeguère T; Peltier A; Diamand R
World J Urol; 2024 May; 42(1):322. PubMed ID: 38747982
[TBL] [Abstract] [Full Text] [Related]
6. First in vitro measurement of VHEE relative biological effectiveness (RBE) in lung and prostate cancer cells using the ARES linac at DESY.
Wanstall HC; Burkart F; Dinter H; Kellermeier M; Kuropka W; Mayet F; Vinatier T; Santina E; Chadwick AL; Merchant MJ; Henthorn NT; Köpke M; Stacey B; Jaster-Merz S; Jones RM
Sci Rep; 2024 May; 14(1):10957. PubMed ID: 38740830
[TBL] [Abstract] [Full Text] [Related]
7. Digital Adoption by an Organization Supporting Informal Caregivers During COVID-19 Pandemic Showing Impact on Service Use, Organizational Performance, and Carers' Well-Being: Retrospective Population-Based Database Study With Embedded User Survey.
Szczepura A; Khan AJ; Wild D; Nelson S; Woodhouse S; Collinson M
JMIR Aging; 2024 May; 7():e46414. PubMed ID: 38739915
[TBL] [Abstract] [Full Text] [Related]
8. A cross-sectional study of ERG expression and the relationship with clinicopathological features of prostate cancer in Southwestern Uganda.
Mitala Y; Ssenkumba B; Birungi A; Kiconco R; Mutakooha MM; Atwine R
Diagn Pathol; 2024 May; 19(1):67. PubMed ID: 38730435
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from prostate cancer Patients.
Roumeliotou A; Strati A; Chamchougia F; Xagara A; Tserpeli V; Smilkou S; Lagopodi E; Christopoulou A; Kontopodis E; Drositis I; Androulakis N; Georgoulias V; Koinis F; Kotsakis A; Lianidou E; Kallergi G
Cells; 2024 May; 13(9):. PubMed ID: 38727318
[TBL] [Abstract] [Full Text] [Related]
10. Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.
Hatami Zharabad S; Mohammadian M; Zohdi Aghdam R; Hassanzadeh Dizaj M; Behrouzkia Z
Mol Biol Rep; 2024 May; 51(1):633. PubMed ID: 38724835
[TBL] [Abstract] [Full Text] [Related]
11. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
Kadry MO; Abdel-Megeed RM
PLoS One; 2024; 19(5):e0302264. PubMed ID: 38723038
[TBL] [Abstract] [Full Text] [Related]
12. Vikil
Tettey CO; Essuman EK; Aninagyei E; Kwansa-Bentum HT; Agyemang Boakye A; Kortei NK; Boamah D
Integr Cancer Ther; 2024; 23():15347354241253846. PubMed ID: 38721848
[TBL] [Abstract] [Full Text] [Related]
13. Associations between knowledge of health issues and health care satisfaction and propensity to complain: a cross-sectional survey of adult men in Denmark.
Birkeland S; Bismark M; Barry MJ; Möller S
BMJ Open; 2024 May; 14(5):e076257. PubMed ID: 38719305
[TBL] [Abstract] [Full Text] [Related]
14. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
[TBL] [Abstract] [Full Text] [Related]
15. Faster both in operative time and functional recovery by the extraperitoneal daVinci SP-based robot-assisted radical prostatectomy: a propensity score matching analysis compared to transperitoneal multiport counterpart.
Ko YH; Jang JY; Kim YU; Kim SW
J Robot Surg; 2024 May; 18(1):205. PubMed ID: 38714543
[TBL] [Abstract] [Full Text] [Related]
16. Identifying risk factors for hypoxemia during emergence from anesthesia in patients undergoing robot-assisted laparoscopic radical prostatectomy.
Zhang Q; Zhu L; Yuan S; Lu S; Zhang X
J Robot Surg; 2024 May; 18(1):200. PubMed ID: 38713381
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of a Cascaded Deep Learning-based Algorithm for prostate Lesion Detection at Biparametric MRI.
Lin Y; Yilmaz EC; Belue MJ; Harmon SA; Tetreault J; Phelps TE; Merriman KM; Hazen L; Garcia C; Yang D; Xu Z; Lay NS; Toubaji A; Merino MJ; Xu D; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
Radiology; 2024 May; 311(2):e230750. PubMed ID: 38713024
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of quantitative whole body PET parameters on [
Ayati N; McIntosh L; Buteau J; Alipour R; Pudis M; Daw N; Jackson P; Hofman MS
Cancer Imaging; 2024 May; 24(1):57. PubMed ID: 38711135
[TBL] [Abstract] [Full Text] [Related]
19. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study.
Duwe G; Schmitteckert M; Haack M; Sparwasser P; Dotzauer R; Thomas A; Tsaur I; Brandt MP; Kurosch M; Mager R; Haferkamp A; Boehm K; Höfner T
World J Urol; 2024 May; 42(1):297. PubMed ID: 38709326
[TBL] [Abstract] [Full Text] [Related]
20. Toward confident prostate cancer detection using ultrasound: a multi-center study.
Wilson PFR; Harmanani M; To MNN; Gilany M; Jamzad A; Fooladgar F; Wodlinger B; Abolmaesumi P; Mousavi P
Int J Comput Assist Radiol Surg; 2024 May; 19(5):841-849. PubMed ID: 38704793
[TBL] [Abstract] [Full Text] [Related]
[Next]
